A cost-effectiveness analysis of lowering residential radon levels in Sweden—Results from a modelling study
Gösta Axelsson and
Health Policy, 2018, vol. 122, issue 6, 687-692
Residential exposure to radon is considered as the second leading cause of lung cancer after smoking. The purpose of this study was to conduct a cost-effectiveness analysis of reducing the indoor radon levels in Sweden from the current reference level of 200 Bq/m3 to the WHO suggested reference level of maximum 100 Bq/m3.
Keywords: Radon; Cost-effectiveness analysis; Lung cancer; Prevention (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations Track citations by RSS feed
Downloads: (external link)
Full text for ScienceDirect subscribers only
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:122:y:2018:i:6:p:687-692
Access Statistics for this article
Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput
More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Dana Niculescu ().